Get to know us

The European & Developing Countries Clinical Trials Partnership (EDCTP) is a public-public partnership between countries in Europe and sub-Saharan Africa, and the European Union.

The EDCTP programme is supported under Horizon 2020, the European Union’s Framework Programme for Research and Innovation.

EDCTP aims to support collaborative research that accelerates the clinical development of new or improved interventions to prevent or treat HIV/AIDS, tuberculosis, malaria and neglected infectious diseases in sub-Saharan Africa.

The second EDCTP programme is implemented as part of the European Framework Programme for Research and Innovation, Horizon 2020.

European Union contribution
The European Union will provide a contribution of up to € 683 million for the 10-year programme (2014-2024), provided this is matched by contributions from the European Participating States.

Participating States
The countries participating in EDCTP as members of the EDCTP Association are:
14 European countries
– Austria, Denmark, Finland, France, Germany, Ireland, Italy, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, UK; and
16 African countries –
Burkina Faso, Cameroon, Congo, Ethiopia, Gabon, The Gambia, Ghana, Mali, Mozambique, Niger, Nigeria, Senegal, South Africa, Tanzania, Uganda and Zambia.
More countries can join.

Angola and Switzerland participate as aspirant members of the EDCTP Association.

The EDCTP Association will implement the second EDCTP programme. The Association is governed by its members, the European and African Participating States, through the General Assembly. The Secretariat executes the activities of the programme. The principal advisory body to the General Assembly and the Secretariat is the Scientific Advisory Committee.